A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

NCT06196879 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Asthma

Interventions

DRUG: Verekitug (UPB-101)
DRUG: Placebo

Sponsor

Upstream Bio Inc.